Disclosure Panels Details Page

Breast Cancer Risk Reduction Panel - Disclosures as of 01/10/2014

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Banu Arun MD AbbVie, Inc.
AstraZeneca Pharmaceuticals LP
Invitae : research paid to the institution
None None None NA
Mary Anne Bergman None None None None NA
Therese Bevers MD Preferred Medicine
Toray International
None None None NA
Graham Colditz MD, DrPH, FAFPHM Centine Corp , St Louis
Grailbio
None None None NA
Kenneth Cowan MD, PhD Merck & Co., Inc. None None None NA -
Mary Daly MD, PhD, FACP None None None None NA
Lauren Gallagher None None None None None
Judy Garber MD, MPH Ambry Genetics
AstraZeneca Pharmaceuticals LP
Invitae Genetics
Myriad Genetic Laboratories, Inc.
Adrienne Helis Melvin Research Foundation
Aleta Bio-Therapeutics
American Association for Cancer Research
American Society of Clinical Oncology
Diane Helis Henry Medical Research Foudation
GTx, Inc.
GV20 Therapeutics
H3 Biomedicine, Inc.
Helix Genetics
James P. Wilmot Foundation Inc.
Konica Minolta
Kronos Bio
Novartis Pharmaceuticals Corporation
Susan G. Komen for the Cure
None Breast Cancer Research Foundation NA -
Mary Gemignani MD None None None None NA
William Gradishar MD Daiichi- Sankyo Co.
Genentech, Inc.
Immunomedics, Inc.
Seattle Genetics, Inc.
AstraZeneca Pharmaceuticals LP
Merck & Co., Inc.
Pfizer Inc.
None None NA
Kristina Gregory MSN, RN, OCN None None None None NA -
Judith Jordan BS None None None None NA
Larissa Korde MD, MPH None Amgen Inc. None None None
Nicole Kounalakis MD None None None None None
Helen Krontiras MD None None None None None -
Rashmi Kumar PhD None None None None NA
Shicha Kumar MD None None None None None -
Allison Kurian MD, MSc None None None None NA -
Christine Laronga MD, FACS None None None None NA -
Loretta Loftus MD, MBA None Greenberg, Traurig Law Firm Expert Witness
Tyme Development Committee
United States Department of Justice Expert Witness
None Amgen Inc. |Eli Lilly and Company|Gilead Sciences, Inc.|Johnson & Johnson|Pfizer Inc. NA
Martin Mahoney MD, PhD None Merck & Co., Inc.
Pfizer Inc.
Merck & Co., Inc.
Pfizer Inc.
sanofi-aventis U.S.
None NA -
Joan McClure MS None None None None NA
Sofia Merajver MD, PhD None None None Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. NA -
Ingrid Meszoely MD None None None None NA
Joanne Mortimer MD, FACP Karyopharm Therapeutics
Puma
None None None NA
Lisa Newman MD, MPH None None None None NA -
Frances Pritchard MD None None None None NA -
Victoria Seewaldt MD None None None None None
Rena Sellin MD None None None None NA -
Charles Shapiro MD None None None None NA -
Michelle Specht MD, FACS None None None None NA
Sarika Trikha PharmD None None None None None -
Kala Visvanathan MD, MHS Cepheid
Optra Health
None None None NA -
Anne Wallace MD, FACS None None None None NA
John Ward MD None None None None NA